Altimmune Inc (ALT)

R&D Expense Growth

15.38%

Quarterly · Period ending:

ALT logo

ALT R&D Expense Growth

Latest reported15.38%
ALT Quarterly R&D Growth (QoQ) (0.00% → 15.38%)
High-resolution chart · PNG

ALT r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Altimmune Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
15.3751%
-12.168%
23.0548%
-13.2049%
8.9025%
-19.9889%
-0.1111%
-6.3909%
-1.5451%
27.0743%
-8.0433%
38.7459%
-23.1666%
-10.0631%
-5.345%
26.6929%
5.8859%
-25.1722%
-30.8875%
120.0573%
11.736%
32.7066%
-47.4793%
2.6981%
130.8755%
85.5762%
-55.6332%
196.4147%
-8.4712%
4.9916%
-35.1899%
-3.8674%
-14.4078%
28.858%
-24.4791%
12.3855%
623.9943%
-49.1393%
15.3909%
8.1798%
11.0823%
-12.1522%
4.0527%
-7.9067%
-24.2373%
-9.9142%
3.6024%
-27.132%
-30.7649%
-16.3685%
60.2944%
-24.8685%
-34.985%
10.2482%
-7.6212%
4.4721%
4.5331%
3.8447%
-7.229%
-18.3798%
2.8129%
52.7402%
-38.2608%
3.9019%
19.9493%
-33.525%
-2.0997%
-19.5975%
66.1824%
6.7141%
-43.3085%
-15.8275%
90.3043%
0.8871%
59.7163%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.